RecruitingPHASE1, PHASE2NCT06625671

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE Participants

Studying Autosomal systemic lupus erythematosus

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
DualityBio Inc.
Principal Investigator
Lily Hu
DualityBio Inc.
Intervention
DB-2304(drug)
Enrollment
148 enrolled
Eligibility
18-70 years · All sexes
Timeline
2024 – 2026

Study locations (4)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06625671 on ClinicalTrials.gov

Other trials for Autosomal systemic lupus erythematosus

Additional recruiting or active studies for the same condition.

See all trials for Autosomal systemic lupus erythematosus →

← Back to all trials